Search for: "Generic Pharmaceutical Services, Inc." Results 441 - 460 of 1,028
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Apr 2017, 8:23 am by Elizabeth Kruska
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579(1993). [read post]
27 Mar 2013, 10:31 am by Seyfarth Shaw LLP
Merrill Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
25 Apr 2011, 12:00 pm by Lucas A. Ferrara, Esq.
    The stocks pumped-and-dumped by conspirators included China World Trade Corporation (CWTD), Pingchuan Pharmaceutical Inc. [read post]
7 May 2012, 10:00 pm by Ben Vernia
Corporate Integrity Agreement In addition to the criminal and civil resolutions, Abbott has also executed a Corporate Integrity Agreement (CIA) with the Department of Health and Human Services, Office of Inspector General (HHS-OIG). [read post]
5 Apr 2013, 1:01 pm by Bexis
Hoffmann-LaRoche Inc., 2013 WL 1191899 (E.D.N.C. [read post]
7 Jun 2007, 10:22 am
Documents listed are accessible through subscription to the GalleryWatch.com service. [read post]
3 Jun 2010, 5:35 am
(Spicy IP) Wellbutrin (Bupropion) – US: Pennsylvania District Court decision signals a new turn in the generic drug preemption debate; a tough pill to swallow for the generic industry: In re Budeprion XL Marketing & Sales Litigation (FDA Law Blog)   [read post]
26 Oct 2007, 2:03 am
Court of Appeal (Civil Division) Neil Martin Ltd v HM Revenue & Customs [2007] EWCA Civ 1041 (25 October 2007) Cadogan & Anor v Sportelli & Anor [2007] EWCA Civ 1042 (25 October 2007) Boudh v Bodh [2007] EWCA Civ 1019 (25 October 2007) AA (Somalia) v SSHD [2007] EWCA Civ 1040 (25 October 2007) Kohn v Wagschal & Ors [2007] EWCA Civ 1022 (24 October 2007) Poole & Ors v HM Treasury [2007] EWCA Civ 1021 (24 October 2007) Wright & Ors, R (on the… [read post]
23 May 2013, 5:00 am by Bexis
  Normally this kind of thing is extremely case specific, and thus not of general interest. [read post]
1 Nov 2023, 9:01 pm by renholding
The JFTC’s investigation appears to have been prompted by an earlier investigation by Japan’s Financial Services Agency into a suspected breach of insurance rules. [read post]